Compile Data Set for Download or QSAR
Report error Found 42 Enz. Inhib. hit(s) with all data for entry = 50034431
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362312(CHEMBL1939740)
Affinity DataIC50: 0.0680nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362304(CHEMBL1939746)
Affinity DataIC50: 0.0710nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362299(CHEMBL1939751)
Affinity DataIC50: 0.0940nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362301(CHEMBL1939749)
Affinity DataIC50: 0.260nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362293(CHEMBL1939738)
Affinity DataIC50: 0.270nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362294(CHEMBL1939737)
Affinity DataIC50: 0.290nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362307(CHEMBL1939736)
Affinity DataIC50: 0.350nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362306(CHEMBL1939735)
Affinity DataIC50: 0.680nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362300(CHEMBL1939750)
Affinity DataIC50: 0.700nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362305(CHEMBL1939745)
Affinity DataIC50: 0.780nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362313(CHEMBL1939739)
Affinity DataIC50: 0.900nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362310(CHEMBL1939743)
Affinity DataIC50: 1.10nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362303(CHEMBL1939747)
Affinity DataIC50: 1.30nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362302(CHEMBL1939748)
Affinity DataIC50: 1.40nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362296(CHEMBL1939753)
Affinity DataIC50: 2nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362298(CHEMBL1939752)
Affinity DataIC50: 4.10nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362297(CHEMBL1938410)
Affinity DataIC50: 4.70nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362295(CHEMBL1939754)
Affinity DataIC50: 5.20nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362308(CHEMBL1939741)
Affinity DataIC50: 6.60nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362309(CHEMBL1939744)
Affinity DataIC50: 23nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362311(CHEMBL1939742)
Affinity DataIC50: 100nMAssay Description:Displacement of [I125]deltorphin from delta-opioid receptor overexpressed in human HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362313(CHEMBL1939739)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362304(CHEMBL1939746)
Affinity DataIC50: 5.40E+3nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362303(CHEMBL1939747)
Affinity DataIC50: 7.30E+3nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362305(CHEMBL1939745)
Affinity DataIC50: 8.70E+3nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362302(CHEMBL1939748)
Affinity DataIC50: 9.90E+3nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362298(CHEMBL1939752)
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362306(CHEMBL1939735)
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362294(CHEMBL1939737)
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362296(CHEMBL1939753)
Affinity DataIC50: 1.30E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362309(CHEMBL1939744)
Affinity DataIC50: 1.30E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362307(CHEMBL1939736)
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362297(CHEMBL1938410)
Affinity DataIC50: 1.50E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362293(CHEMBL1939738)
Affinity DataIC50: 1.50E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362299(CHEMBL1939751)
Affinity DataIC50: 1.70E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362311(CHEMBL1939742)
Affinity DataIC50: 1.80E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362312(CHEMBL1939740)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362308(CHEMBL1939741)
Affinity DataIC50: 2.80E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362310(CHEMBL1939743)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362301(CHEMBL1939749)
Affinity DataIC50: 3.30E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362300(CHEMBL1939750)
Affinity DataIC50: 3.30E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50362295(CHEMBL1939754)
Affinity DataIC50: 3.30E+4nMAssay Description:Inhibition of human ErgMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed